An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins

doi:10.1084/jem.183.2.527

This Article

	Full Text (PDF, 784K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Skipper, J. C.
	Articles by Engelhard, V. H.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Skipper, J. C.
	Articles by Engelhard, V. H.


Social Bookmarking

	What's this?

ARTICLES

An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins

JC Skipper, RC Hendrickson, PH Gulden, V Brichard, A Van Pel, Y Chen, J Shabanowitz, T Wolfel, CL Slingluff Jr, T Boon, DF Hunt and VH Engelhard
Department of Microbiology, University of Virginia, Charlottesville 22908, USA.

T lymphocytes recognize antigens consisting of peptides presented by class I and II major histocompatibility complex (MHC) molecules. The peptides identified so far have been predictable from the amino acid sequences of proteins. We have identified the natural peptide target of a CTL clone that recognizes the tyrosinase gene product on melanoma cells. The peptide results from posttranslational conversion of asparagine to aspartic acid. This change is of central importance for peptide recognition by melanoma-specific T cells, but has no impact on peptide binding to the MHC molecule. This posttranslational modification has not been previously described for any MHC-associated peptide and represents the first demonstration of posttranslational modification of a naturally processed class I-associated peptide. This observation is relevant to the identification and prediction of potential peptide antigens. The most likely mechanism for production of this peptide leads to the suggestion that antigenic peptides can be derived from proteins that are translated into the endoplasmic reticulum.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Michaeli, Y., Denkberg, G., Sinik, K., Lantzy, L., Chih-Sheng, C., Beauverd, C., Ziv, T., Romero, P., Reiter, Y. (2009). Expression Hierarchy of T Cell Epitopes from Melanoma Differentiation Antigens: Unexpected High Level Presentation of Tyrosinase-HLA-A2 Complexes Revealed by Peptide-Specific, MHC-Restricted, TCR-Like Antibodies. J. Immunol. 182: 6328-6341 [Abstract] [Full Text]
Ostankovitch, M., Altrich-VanLith, M., Robila, V., Engelhard, V. H. (2009). N-Glycosylation Enhances Presentation of a MHC Class I-Restricted Epitope from Tyrosinase. J. Immunol. 182: 4830-4835 [Abstract] [Full Text]
Weng, X., Lu, S., Zhong, M., Liang, Z., Shen, G., Chen, J., Wu, X. (2009). Allo-restricted CTLs generated by coculturing of PBLs and autologous monocytes loaded with allogeneic peptide/HLA/IgG1-Fc fusion protein. J. Leukoc. Biol. 85: 574-581 [Abstract] [Full Text]
Kario, E., Tirosh, B., Ploegh, H. L., Navon, A. (2008). N-Linked Glycosylation Does Not Impair Proteasomal Degradation but Affects Class I Major Histocompatibility Complex Presentation. J. Biol. Chem. 283: 244-254 [Abstract] [Full Text]
Gasteiger, G., Kastenmuller, W., Ljapoci, R., Sutter, G., Drexler, I. (2007). Cross-Priming of Cytotoxic T Cells Dictates Antigen Requisites for Modified Vaccinia Virus Ankara Vector Vaccines. J. Virol. 81: 11925-11936 [Abstract] [Full Text]
Slingluff, C. L. Jr., Petroni, G. R., Chianese-Bullock, K. A., Smolkin, M. E., Hibbitts, S., Murphy, C., Johansen, N., Grosh, W. W., Yamshchikov, G. V., Neese, P. Y., Patterson, J. W., Fink, R., Rehm, P. K. (2007). Immunologic and Clinical Outcomes of a Randomized Phase II Trial of Two Multipeptide Vaccines for Melanoma in the Adjuvant Setting. Clin. Cancer Res. 13: 6386-6395 [Abstract] [Full Text]
Stern, L. J. (2007). Characterizing MHC-Associated Peptides by Mass Spectrometry. J. Immunol. 179: 2667-2668 [Full Text]
Ninkovic, T., Hanisch, F.-G. (2007). O-Glycosylated Human MUC1 Repeats Are Processed In Vitro by Immunoproteasomes. J. Immunol. 179: 2380-2388 [Abstract] [Full Text]
Doyle, H. A., Zhou, J., Wolff, M. J., Harvey, B. P., Roman, R. M., Gee, R. J., Koski, R. A., Mamula, M. J. (2006). Isoaspartyl Post-translational Modification Triggers Anti-tumor T and B Lymphocyte Immunity. J. Biol. Chem. 281: 32676-32683 [Abstract] [Full Text]
Altrich-VanLith, M. L., Ostankovitch, M., Polefrone, J. M., Mosse, C. A., Shabanowitz, J., Hunt, D. F., Engelhard, V. H. (2006). Processing of a Class I-Restricted Epitope from Tyrosinase Requires Peptide N-Glycanase and the Cooperative Action of Endoplasmic Reticulum Aminopeptidase 1 and Cytosolic Proteases. J. Immunol. 177: 5440-5450 [Abstract] [Full Text]
Flechtner, J. B., Cohane, K. P., Mehta, S., Slusarewicz, P., Leonard, A. K., Barber, B. H., Levey, D. L., Andjelic, S. (2006). High-Affinity Interactions between Peptides and Heat Shock Protein 70 Augment CD8+ T Lymphocyte Immune Responses. J. Immunol. 177: 1017-1027 [Abstract] [Full Text]
Meiring, H. D., Soethout, E. C., Poelen, M. C. M., Mooibroek, D., Hoogerbrugge, R., Timmermans, H., Boog, C. J., Heck, A. J. R., de Jong, A. P. J. M., van Els, C. A. C. M. (2006). Stable Isotope Tagging of Epitopes: A Highly Selective Strategy For The Identification Of Major Histocompatibility Complex Class I-Associated Peptides Induced Upon Viral Infection. Mol. Cell. Proteomics 5: 902-913 [Abstract] [Full Text]
Frey, A. B., Monu, N. (2006). Effector-phase tolerance: another mechanism of how cancer escapes antitumor immune response. J. Leukoc. Biol. 79: 652-662 [Abstract] [Full Text]
Chapiro, J., Claverol, S., Piette, F., Ma, W., Stroobant, V., Guillaume, B., Gairin, J.-E., Morel, S., Burlet-Schiltz, O., Monsarrat, B., Boon, T., Van den Eynde, B. J. (2006). Destructive Cleavage of Antigenic Peptides Either by the Immunoproteasome or by the Standard Proteasome Results in Differential Antigen Presentation. J. Immunol. 176: 1053-1061 [Abstract] [Full Text]
Luiten, R. M., Kueter, E. W.M., Mooi, W., Gallee, M. P.W., Rankin, E. M., Gerritsen, W. R., Clift, S. M., Nooijen, W. J., Weder, P., van de Kasteele, W. F., Sein, J., van den Berk, P. C.M., Nieweg, O. E., Berns, A. M., Spits, H., de Gast, G. C. (2005). Immunogenicity, Including Vitiligo, and Feasibility of Vaccination With Autologous GM-CSF-Transduced Tumor Cells in Metastatic Melanoma Patients. JCO 23: 8978-8991 [Abstract] [Full Text]
Hofmann, S., Gluckmann, M., Kausche, S., Schmidt, A., Corvey, C., Lichtenfels, R., Huber, C., Albrecht, C., Karas, M., Herr, W. (2005). Rapid and Sensitive Identification of Major Histocompatibility Complex Class I-associated Tumor Peptides by Nano-LC MALDI MS/MS. Mol. Cell. Proteomics 4: 1888-1897 [Abstract] [Full Text]
Yamshchikov, G. V., Mullins, D. W., Chang, C.-C., Ogino, T., Thompson, L., Presley, J., Galavotti, H., Aquila, W., Deacon, D., Ross, W., Patterson, J. W., Engelhard, V. H., Ferrone, S., Slingluff, C. L. Jr (2005). Sequential Immune Escape and Shifting of T Cell Responses in a Long-Term Survivor of Melanoma. J. Immunol. 174: 6863-6871 [Abstract] [Full Text]
Herzog, J., Maekawa, Y., Cirrito, T. P., Illian, B. S., Unanue, E. R. (2005). Activated antigen-presenting cells select and present chemically modified peptides recognized by unique CD4 T cells. Proc. Natl. Acad. Sci. USA 102: 7928-7933 [Abstract] [Full Text]
Ostankovitch, M., Robila, V., Engelhard, V. H. (2005). Regulated Folding of Tyrosinase in the Endoplasmic Reticulum Demonstrates That Misfolded Full-Length Proteins Are Efficient Substrates for Class I Processing and Presentation. J. Immunol. 174: 2544-2551 [Abstract] [Full Text]
Slingluff, C. L. Jr, Petroni, G. R., Yamshchikov, G. V., Hibbitts, S., Grosh, W. W., Chianese-Bullock, K. A., Bissonette, E. A., Barnd, D. L., Deacon, D. H., Patterson, J. W., Parekh, J., Neese, P. Y., Woodson, E. M.H., Wiernasz, C. J., Merrill, P. (2004). Immunologic and Clinical Outcomes of Vaccination With a Multiepitope Melanoma Peptide Vaccine Plus Low-Dose Interleukin-2 Administered Either Concurrently or on a Delayed Schedule. JCO 22: 4474-4485 [Abstract] [Full Text]
Azuma, K., Sasada, T., Takedatsu, H., Shomura, H., Koga, M., Maeda, Y., Yao, A., Hirai, T., Takabayashi, A., Shichijo, S., Itoh, K. (2004). Ran, a Small GTPase Gene, Encodes Cytotoxic T Lymphocyte (CTL) Epitopes Capable of Inducing HLA-A33-restricted and Tumor-Reactive CTLs in Cancer Patients. Clin. Cancer Res. 10: 6695-6702 [Abstract] [Full Text]
Di Nicola, M., Carlo-Stella, C., Mortarini, R., Baldassari, P., Guidetti, A., Gallino, G. F., Del Vecchio, M., Ravagnani, F., Magni, M., Chaplin, P., Cascinelli, N., Parmiani, G., Gianni, A. M., Anichini, A. (2004). Boosting T Cell-Mediated Immunity to Tyrosinase by Vaccinia Virus-Transduced, CD34+-Derived Dendritic Cell Vaccination: A Phase I Trial in Metastatic Melanoma. Clin. Cancer Res. 10: 5381-5390 [Abstract] [Full Text]
Thomas, A. M., Santarsiero, L. M., Lutz, E. R., Armstrong, T. D., Chen, Y.-C., Huang, L.-Q., Laheru, D. A., Goggins, M., Hruban, R. H., Jaffee, E. M. (2004). Mesothelin-specific CD8+ T Cell Responses Provide Evidence of In Vivo Cross-Priming by Antigen-Presenting Cells in Vaccinated Pancreatic Cancer Patients. JEM 200: 297-306 [Abstract] [Full Text]
Vigneron, N., Stroobant, V., Chapiro, J., Ooms, A., Degiovanni, G., Morel, S., van der Bruggen, P., Boon, T., Van den Eynde, B. J. (2004). An Antigenic Peptide Produced by Peptide Splicing in the Proteasome. Science 304: 587-590 [Abstract] [Full Text]
Sasada, T., Takedatsu, H., Azuma, K., Koga, M., Maeda, Y., Shichijo, S., Shoumura, H., Hirai, T., Takabayashi, A., Itoh, K. (2004). Immediate Early Response Gene X-1, a Stress-Inducible Antiapoptotic Gene, Encodes Cytotoxic T-Lymphocyte (CTL) Epitopes Capable of Inducing Human Leukocyte Antigen-A33-Restricted and Tumor-Reactive CTLs in Gastric Cancer Patients. Cancer Res. 64: 2882-2888 [Abstract] [Full Text]
Purcell, A. W., Gorman, J. J. (2004). Immunoproteomics: Mass Spectrometry-based Methods to Study the Targets of the Immune Response. Mol. Cell. Proteomics 3: 193-208 [Abstract] [Full Text]
Dadaglio, G., Morel, S., Bauche, C., Moukrim, Z., Lemonnier, F. A., Van den Eynde, B. J., Ladant, D., Leclerc, C. (2003). Recombinant adenylate cyclase toxin of Bordetella pertussis induces cytotoxic T lymphocyte responses against HLA*0201-restricted melanoma epitopes. Int Immunol 15: 1423-1430 [Abstract] [Full Text]
Slingluff, C. L. Jr, Petroni, G. R., Yamshchikov, G. V., Barnd, D. L., Eastham, S., Galavotti, H., Patterson, J. W., Deacon, D. H., Hibbitts, S., Teates, D., Neese, P. Y., Grosh, W. W., Chianese-Bullock, K. A., Woodson, E. M.H., Wiernasz, C. J., Merrill, P., Gibson, J., Ross, M., Engelhard, V. H. (2003). Clinical and Immunologic Results of a Randomized Phase II Trial of Vaccination Using Four Melanoma Peptides Either Administered in Granulocyte-Macrophage Colony-Stimulating Factor in Adjuvant or Pulsed on Dendritic Cells. JCO 21: 4016-4026 [Abstract] [Full Text]
Admon, A., Barnea, E., Ziv, T. (2003). Tumor Antigens and Proteomics from the Point of View of the Major Histocompatibility Complex Peptides. Mol. Cell. Proteomics 2: 388-398 [Abstract] [Full Text]
Mortarini, R., Piris, A., Maurichi, A., Molla, A., Bersani, I., Bono, A., Bartoli, C., Santinami, M., Lombardo, C., Ravagnani, F., Cascinelli, N., Parmiani, G., Anichini, A. (2003). Lack of Terminally Differentiated Tumor-specific CD8+ T Cells at Tumor Site in Spite of Antitumor Immunity to Self-Antigens in Human Metastatic Melanoma. Cancer Res. 63: 2535-2545 [Abstract] [Full Text]
Uenaka, A., Hirano, Y., Hata, H., Win, S., Aji, T., Tanaka, M., Ono, T., Skipper, J. C. A., Shimizu, K., Nakayama, E. (2003). Cryptic CTL Epitope on a Murine Sarcoma Meth A Generated by Exon Extension as a Novel Mechanism. J. Immunol. 170: 4862-4868 [Abstract] [Full Text]
Pullarkat, V., Lee, P. P., Scotland, R., Rubio, V., Groshen, S., Gee, C., Lau, R., Snively, J., Sian, S., Woulfe, S. L., Wolfe, R. A., Weber, J. S. (2003). A Phase I Trial of SD-9427 (Progenipoietin) with a Multipeptide Vaccine for Resected Metastatic Melanoma. Clin. Cancer Res. 9: 1301-1312 [Abstract] [Full Text]
Lee, S.-Y., Obata, Y., Yoshida, M., Stockert, E., Williamson, B., Jungbluth, A. A., Chen, Y.-T., Old, L. J., Scanlan, M. J. (2003). Immunomic analysis of human sarcoma. Proc. Natl. Acad. Sci. USA 100: 2651-2656 [Abstract] [Full Text]
Tatsumi, T., Kierstead, L. S., Ranieri, E., Gesualdo, L., Schena, F. P., Finke, J. H., Bukowski, R. M., Brusic, V., Sidney, J., Sette, A., Logan, T. F., Kasamon, Y. L., Slingluff, C. L. Jr., Kirkwood, J. M., Storkus, W. J. (2003). MAGE-6 Encodes HLA-DR{beta}1*0401-presented Epitopes Recognized by CD4+ T Cells from Patients with Melanoma or Renal Cell Carcinoma. Clin. Cancer Res. 9: 947-954 [Abstract] [Full Text]
Roszkowski, J. J., Yu, D. C., Rubinstein, M. P., McKee, M. D., Cole, D. J., Nishimura, M. I. (2003). CD8-Independent Tumor Cell Recognition Is a Property of the T Cell Receptor and Not the T Cell. J. Immunol. 170: 2582-2589 [Abstract] [Full Text]
Paster, W., Kalat, M., Zehetner, M., Schweighoffer, T. (2002). Structural Elements of a Protein Antigen Determine Immunogenicity of the Embedded MHC Class I-Restricted T Cell Epitope. J. Immunol. 169: 2937-2946 [Abstract] [Full Text]
Wolchok, J. D., Chapman, P. B., Mitchell, M. S. (2002). Phase I Trial of Adoptive Immunotherapy With Cytolytic T Lymphocytes Immunized Against a Tyrosinase Epitope. JCO 20: 3176-3177 [Full Text]
Konopitzky, R., Konig, U., Meyer, R. G., Sommergruber, W., Wolfel, T., Schweighoffer, T. (2002). Identification of HLA-A*0201-Restricted T Cell Epitopes Derived from the Novel Overexpressed Tumor Antigen Calcium-Activated Chloride Channel 2. J. Immunol. 169: 540-547 [Abstract] [Full Text]
Huarte, E., Sarobe, P., Lu, J., Casares, N., Lasarte, J. J., Dotor, J., Ruiz, M., Prieto, J., Celis, E., Borras-Cuesta, F. (2002). Enhancing Immunogenicity of a CTL Epitope from Carcinoembryonic Antigen by Selective Amino Acid Replacements. Clin. Cancer Res. 8: 2336-2344 [Abstract] [Full Text]
Rubio-Godoy, V., Pinilla, C., Dutoit, V., Borras, E., Simon, R., Zhao, Y., Cerottini, J.-C., Romero, P., Houghten, R., Valmori, D. (2002). Toward Synthetic Combinatorial Peptide Libraries in Positional Scanning Format (PS-SCL)-based Identification of CD8+ Tumor-reactive T-Cell Ligands: A Comparative Analysis of PS-SCL Recognition by a Single Tumor-reactive CD8+ Cytolytic T-Lymphocyte Clone. Cancer Res. 62: 2058-2063 [Abstract] [Full Text]
Golovina, T. N., Wherry, E. J., Bullock, T. N. J., Eisenlohr, L. C. (2002). Efficient and Qualitatively Distinct MHC Class I-Restricted Presentation of Antigen Targeted to the Endoplasmic Reticulum. J. Immunol. 168: 2667-2675 [Abstract] [Full Text]
Valmori, D., Scheibenbogen, C., Dutoit, V., Nagorsen, D., Asemissen, A. M., Rubio-Godoy, V., Rimoldi, D., Guillaume, P., Romero, P., Schadendorf, D., Lipp, M., Dietrich, P.-Y., Thiel, E., Cerottini, J.-C., Lienard, D., Keilholz, U. (2002). Circulating Tumor-reactive CD8+ T Cells in Melanoma Patients Contain a CD45RA+CCR7- Effector Subset Exerting ex Vivo Tumor-specific Cytolytic Activity. Cancer Res. 62: 1743-1750 [Abstract] [Full Text]
Pietra, G., Mortarini, R., Parmiani, G., Anichini, A. (2001). Phases of Apoptosis of Melanoma Cells, but not of Normal Melanocytes, Differently Affect Maturation of Myeloid Dendritic Cells. Cancer Res. 61: 8218-8226 [Abstract] [Full Text]
Mullins, D. W., Bullock, T. N. J., Colella, T. A., Robila, V. V., Engelhard, V. H. (2001). Immune Responses to the HLA-A*0201-Restricted Epitopes of Tyrosinase and Glycoprotein 100 Enable Control of Melanoma Outgrowth in HLA-A*0201-Transgenic Mice. J. Immunol. 167: 4853-4860 [Abstract] [Full Text]
Lautscham, G., Mayrhofer, S., Taylor, G., Haigh, T., Leese, A., Rickinson, A., Blake, N. (2001). Processing of a Multiple Membrane Spanning Epstein-Barr Virus Protein for Cd8+T Cell Recognition Reveals a Proteasome-Dependent, Transporter Associated with Antigen Processing-Independent Pathway. JEM 194: 1053-1068 [Abstract] [Full Text]
Cirrito, T. P., Pu, Z., Deck, M. B., Unanue, E. R. (2001). Deamidation of Asparagine in a Major Histocompatibility Complex-Bound Peptide Affects T Cell Recognition but Does Not Explain Type B Reactivity. JEM 194: 1165-1170 [Abstract] [Full Text]
Lapointe, R., Royal, R. E., Reeves, M. E., Altomare, I., Robbins, P. F., Hwu, P. (2001). Retrovirally Transduced Human Dendritic Cells Can Generate T Cells Recognizing Multiple MHC Class I and Class II Epitopes from the Melanoma Antigen Glycoprotein 100. J. Immunol. 167: 4758-4764 [Abstract] [Full Text]
Slingluff, C. L. Jr., Yamshchikov, G., Neese, P., Galavotti, H., Eastham, S., Engelhard, V. H., Kittlesen, D., Deacon, D., Hibbitts, S., Grosh, W. W., Petroni, G., Cohen, R., Wiernasz, C., Patterson, J. W., Conway, B. P., Ross, W. G. (2001). Phase I Trial of a Melanoma Vaccine with gp100280-288 Peptide and Tetanus Helper Peptide in Adjuvant: Immunologic and Clinical Outcomes. Clin. Cancer Res. 7: 3012-3024 [Abstract] [Full Text]
Tangri, S., Ishioka, G. Y., Huang, X., Sidney, J., Southwood, S., Fikes, J., Sette, A. (2001). Structural Features of Peptide Analogs of Human Histocompatibility Leukocyte Antigen Class I Epitopes That Are More Potent and Immunogenic than Wild-Type Peptide. JEM 194: 833-846 [Abstract] [Full Text]
Lee, P., Wang, F., Kuniyoshi, J., Rubio, V., Stuges, T., Groshen, S., Gee, C., Lau, R., Jeffery, G., Margolin, K., Marty, V., Weber, J. (2001). Effects of Interleukin-12 on the Immune Response to a Multipeptide Vaccine for Resected Metastatic Melanoma. JCO 19: 3836-3847 [Abstract] [Full Text]
Pinilla, C., Rubio-Godoy, V., Dutoit, V., Guillaume, P., Simon, R., Zhao, Y., Houghten, R. A., Cerottini, J.-C., Romero, P., Valmori, D. (2001). Combinatorial Peptide Libraries as an Alternative Approach to the Identification of Ligands for Tumor-reactive Cytolytic T Lymphocytes. Cancer Res. 61: 5153-5160 [Abstract] [Full Text]
Golgher, D., Korangy, F., Gao, B., Gorski, K., Jaffee, E., Edidin, M., Pardoll, D. M., Elliott, T. (2001). An Immunodominant MHC Class II-Restricted Tumor Antigen Is Conformation Dependent and Binds to the Endoplasmic Reticulum Chaperone, Calreticulin. J. Immunol. 167: 147-155 [Abstract] [Full Text]
Moris, A., Teichgraber, V., Gauthier, L., Buhring, H.-J., Rammensee, H.-G. (2001). Cutting Edge: Characterization of Allorestricted and Peptide-Selective Alloreactive T Cells Using HLA-Tetramer Selection. J. Immunol. 166: 4818-4821 [Abstract] [Full Text]
Rudd, P. M., Elliott, T., Cresswell, P., Wilson, I. A., Dwek, R. A. (2001). Glycosylation and the Immune System. Science 291: 2370-2376 [Abstract] [Full Text]
Ono, T., Kurashige, T., Harada, N., Noguchi, Y., Saika, T., Niikawa, N., Aoe, M., Nakamura, S., Higashi, T., Hiraki, A., Wada, H., Kumon, H., Old, L. J., Nakayama, E. (2001). Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen. Proc. Natl. Acad. Sci. USA 98: 3282-3287 [Abstract] [Full Text]
Zarling, A. L., Ficarro, S. B., White, F. M., Shabanowitz, J., Hunt, D. F., Engelhard, V. H. (2000). Phosphorylated Peptides Are Naturally Processed and Presented by Major Histocompatibility Complex Class I Molecules in Vivo. JEM 192: 1755-1762 [Abstract] [Full Text]
Gnjatic, S., Nagata, Y., Jager, E., Stockert, E., Shankara, S., Roberts, B. L., Mazzara, G. P., Lee, S. Y., Dunbar, P. R., Dupont, B., Cerundolo, V., Ritter, G., Chen, Y.-T., Knuth, A., Old, L. J. (2000). Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele. Proc. Natl. Acad. Sci. USA 97: 10917-10922 [Abstract] [Full Text]
Appay, V., Dunbar, P. R., Cerundolo, V., McMichael, A., Czaplewski, L., Rowland-Jones, S. (2000). RANTES activates antigen-specific cytotoxic T lymphocytes in a mitogen-like manner through cell surface aggregation. Int Immunol 12: 1173-1182 [Abstract] [Full Text]
Yague, J., Alvarez, I., Rognan, D., Ramos, M., Vazquez, J., de Castro, J. A. L. (2000). An N-Acetylated Natural Ligand of Human Histocompatibility Leukocyte Antigen (Hla)-B39: Classical Major Histocompatibility Complex Class I Proteins Bind Peptides with a Blocked Nh2 Terminus in Vivo. JEM 191: 2083-2092 [Abstract] [Full Text]
Crotzer, V. L., Christian, R. E., Brooks, J. M., Shabanowitz, J., Settlage, R. E., Marto, J. A., White, F. M., Rickinson, A. B., Hunt, D. F., Engelhard, V. H. (2000). Immunodominance Among EBV-Derived Epitopes Restricted by HLA-B27 Does Not Correlate with Epitope Abundance in EBV-Transformed B-Lymphoblastoid Cell Lines. J. Immunol. 164: 6120-6129 [Abstract] [Full Text]
Lopez, D., Gil-Torregrosa, B. C., Bergmann, C., Del Val, M. (2000). Sequential Cleavage by Metallopeptidases and Proteasomes Is Involved in Processing HIV-1 ENV Epitope for Endogenous MHC Class I Antigen Presentation. J. Immunol. 164: 5070-5077 [Abstract] [Full Text]
Colella, T. A., Bullock, T. N.J., Russell, L. B., Mullins, D. W., Overwijk, W. W., Luckey, C. J., Pierce, R. A., Restifo, N. P., Engelhard, V. H. (2000). Self-Tolerance to the Murine Homologue of a Tyrosinase-Derived Melanoma Antigen: Implications for Tumor Immunotherapy. JEM 191: 1221-1232 [Abstract] [Full Text]
Bullock, T. N. J., Colella, T. A., Engelhard, V. H. (2000). The Density of Peptides Displayed by Dendritic Cells Affects Immune Responses to Human Tyrosinase and gp100 in HLA-A2 Transgenic Mice. J. Immunol. 164: 2354-2361 [Abstract] [Full Text]
Van den Eynde, B. J., Gaugler, B., Probst-Kepper, M., Michaux, L., Devuyst, O., Lorge, F., Weynants, P., Boon, T. (1999). A New Antigen Recognized by Cytolytic T Lymphocytes on a Human Kidney Tumor Results from Reverse Strand Transcription. JEM 190: 1793-1800 [Abstract] [Full Text]
Hudrisier, D., Riond, J., Mazarguil, H., Oldstone, M. B. A., Gairin, J. E. (1999). Genetically Encoded and Post-translationally Modified Forms of a Major Histocompatibility Complex Class I-restricted Antigen Bearing a Glycosylation Motif Are Independently Processed and Co-presented to Cytotoxic T Lymphocytes. J. Biol. Chem. 274: 36274-36280 [Abstract] [Full Text]
Nishimura, M. I., Avichezer, D., Custer, M. C., Lee, C. S., Chen, C., Parkhurst, M. R., Diamond, R. A., Robbins, P. F., Schwartzentruber, D. J., Rosenberg, S. A. (1999). MHC Class I-restricted Recognition of a Melanoma Antigen by a Human CD4+ Tumor Infiltrating Lymphocyte. Cancer Res. 59: 6230-6238 [Abstract] [Full Text]
Gomi, S., Nakao, M., Niiya, F., Imamura, Y., Kawano, K., Nishizaka, S., Hayashi, A., Sobao, Y., Oizumi, K., Itoh, K. (1999). A Cyclophilin B Gene Encodes Antigenic Epitopes Recognized by HLA-A24-Restricted and Tumor-Specific CTLs. J. Immunol. 163: 4994-5004 [Abstract] [Full Text]
Drexler, I., Antunes, E., Schmitz, M., Wolfel, T., Huber, C., Erfle, V., Rieber, P., Theobald, M., Sutter, G. (1999). Modified Vaccinia Virus Ankara for Delivery of Human Tyrosinase as Melanoma-associated Antigen: Induction of Tyrosinase- and Melanoma-specific Human Leukocyte Antigen A*0201-restricted Cytotoxic T Cells in Vitro and in Vivo. Cancer Res. 59: 4955-4963 [Abstract] [Full Text]
Pittet, M. J., Valmori, D., Dunbar, P. R., Speiser, D. E., Lienard, D., Lejeune, F., Fleischhauer, K., Cerundolo, V., Cerottini, J.-C., Romero, P. (1999). High Frequencies of Naive Melan-a/Mart-1-Specific Cd8+ T Cells in a Large Proportion of Human Histocompatibility Leukocyte Antigen (Hla)-A2 Individuals. JEM 190: 705-716 [Abstract] [Full Text]
Chaux, P., Luiten, R., Demotte, N., Vantomme, V., Stroobant, V., Traversari, C., Russo, V., Schultz, E., Cornelis, G. R., Boon, T., van der Bruggen, P. (1999). Identification of Five MAGE-A1 Epitopes Recognized by Cytolytic T Lymphocytes Obtained by In Vitro Stimulation with Dendritic Cells Transduced with MAGE-A1. J. Immunol. 163: 2928-2936 [Abstract] [Full Text]
Mamula, M. J., Gee, R. J., Elliott, J. I., Sette, A., Southwood, S., Jones, P.-J., Blier, P. R. (1999). Isoaspartyl Post-translational Modification Triggers Autoimmune Responses to Self-proteins. J. Biol. Chem. 274: 22321-22327 [Abstract] [Full Text]
Valmori, D., J. Pittet, M., Vonarbourg, C., Rimoldi, D., Lienard, D., Speiser, D., Dunbar, R., Cerundolo, V., Cerottini, J.-C., Romero, P. (1999). Analysis of the Cytolytic T Lymphocyte Response of Melanoma Patients to the Naturally HLA-A*0201-associated Tyrosinase Peptide 368-376. Cancer Res. 59: 4050-4055 [Abstract] [Full Text]
Yang, D., Nakao, M., Shichijo, S., Sasatomi, T., Takasu, H., Matsumoto, H., Mori, K., Hayashi, A., Yamana, H., Shirouzu, K., Itoh, K. (1999). Identification of a Gene Coding for a Protein Possessing Shared Tumor Epitopes Capable of Inducing HLA-A24-restricted Cytotoxic T Lymphocytes inCancer Patients. Cancer Res. 59: 4056-4063 [Abstract] [Full Text]
Haurum, J. S., Hoier, I. B., Arsequell, G., Neisig, A., Valencia, G., Zeuthen, J., Neefjes, J., Elliott, T. (1999). Presentation of Cytosolic Glycosylated Peptides by Human Class I Major Histocompatibility Complex Molecules in Vivo. JEM 190: 145-150 [Abstract] [Full Text]
Butterfield, L. H., Koh, A., Meng, W., Vollmer, C. M., Ribas, A., Dissette, V., Lee, E., Glaspy, J. A., McBride, W. H., Economou, J. S. (1999). Generation of Human T-cell Responses to an HLA-A2.1-restricted Peptide Epitope Derived from {{alpha}}-Fetoprotein. Cancer Res. 59: 3134-3142 [Abstract] [Full Text]
Ferris, R. L., Hall, C., Sipsas, N. V., Safrit, J. T., Trocha, A., Koup, R. A., Johnson, R. P., Siliciano, R. F. (1999). Processing of HIV-1 Envelope Glycoprotein for Class I-Restricted Recognition: Dependence on TAP1/2 and Mechanisms for Cytosolic Localization. J. Immunol. 162: 1324-1332 [Abstract] [Full Text]
Selby, M., Erickson, A., Dong, C., Cooper, S., Parham, P., Houghton, M., Walker, C. M. (1999). Hepatitis C Virus Envelope Glycoprotein E1 Originates in the Endoplasmic Reticulum and Requires Cytoplasmic Processing for Presentation by Class I MHC Molecules. J. Immunol. 162: 669-676 [Abstract] [Full Text]
Valmori, D., Gervois, N., Rimoldi, D., Fonteneau, J.-F., Bonelo, A., Lienard, D., Rivoltini, L., Jotereau, F., Cerottini, J.-C., Romero, P. (1998). Diversity of the Fine Specificity Displayed by HLA-A*0201-Restricted CTL Specific for the Immunodominant Melan-A/MART-1 Antigenic Peptide. J. Immunol. 161: 6956-6962 [Abstract] [Full Text]
Kawakami, Y., Robbins, P. F., Wang, X., Tupesis, J. P., Parkhurst, M. R., Kang, X., Sakaguchi, K., Appella, E., Rosenberg, S. A. (1998). Identification of New Melanoma Epitopes on Melanosomal Proteins Recognized by Tumor Infiltrating T Lymphocytes Restricted by HLA-A1, -A2, and -A3 Alleles. J. Immunol. 161: 6985-6992 [Abstract] [Full Text]
Romero, P., Rod Dunbar, P., Valmori, D., Pittet, M., Ogg, G. S., Rimoldi, D., Chen, J.-L., Lienard, D., Cerottini, J.-C., Cerundolo, V. (1998). Ex Vivo Staining of Metastatic Lymph Nodes by Class I Major Histocompatibility Complex Tetramers Reveals High Numbers of Antigen-experienced Tumor-specific Cytolytic T Lymphocytes. JEM 188: 1641-1650 [Abstract] [Full Text]
Ogg, G. S., Rod Dunbar, P., Romero, P., Chen, J.-L., Cerundolo, V. (1998). High Frequency of Skin-homing Melanocyte-specific Cytotoxic T Lymphocytes in Autoimmune Vitiligo. JEM 188: 1203-1208 [Abstract] [Full Text]
Luckey, C. J., King, G. M., Marto, J. A., Venketeswaran, S., Maier, B. F., Crotzer, V. L., Colella, T. A., Shabanowitz, J., Hunt, D. F., Engelhard, V. H. (1998). Proteasomes Can Either Generate or Destroy MHC Class I Epitopes: Evidence for Nonproteasomal Epitope Generation in the Cytosol. J. Immunol. 161: 112-121 [Abstract] [Full Text]
Ostankovitch, M., Buzyn, A., Bonhomme, D., Connan, F., Bouscary, D., Heshmati, F., Dreyfus, F., Choppin, J., Guillet, J.-G. (1998). Antileukemic HLA-Restricted T-Cell Clones Generated With Naturally Processed Peptides Eluted From Acute Myeloblastic Leukemia Blasts. Blood 92: 19-24 [Abstract] [Full Text]
Kittlesen, D. J., Thompson, L. W., Gulden, P. H., Skipper, J. C. A., Colella, T. A., Shabanowitz, J. A., Hunt, D. F., Engelhard, V. H., Slingluff, C. L. Jr. (1998). Human Melanoma Patients Recognize an HLA-A1-Restricted CTL Epitope from Tyrosinase Containing Two Cysteine Residues: Implications for Tumor Vaccine Development. J. Immunol. 160: 2099-2106 [Abstract] [Full Text]
Purcell, A. W., Chen, W., Ede, N. J., Gorman, J. J., Fecondo, J. V., Jackson, D. C., Zhao, Y., McCluskey, J. (1998). Avoidance of Self-Reactivity Results in Skewed CTL Responses to Rare Components of Synthetic Immunogens. J. Immunol. 160: 1085-1090 [Abstract] [Full Text]
Mosse, C. A., Meadows, L., Luckey, C. J., Kittlesen, D. J., Huczko, E. L., Slingluff, C. L. Jr., Shabanowitz, J., Hunt, D. F., Engelhard, V. H. (1998). The Class I Antigen-processing Pathway for the Membrane Protein Tyrosinase Involves Translation in the Endoplasmic Reticulum and Processing in the Cytosol. JEM 187: 37-48 [Abstract] [Full Text]
Bacik, I., Snyder, H. L., Anton, L. C., Russ, G., Chen, W., Bennink, J. R., Urge, L., Otvos, L., Dudkowska, B., Eisenlohr, L., Yewdell, J. W. (1997). Introduction of a Glycosylation Site into a Secreted Protein Provides Evidence for an Alternative Antigen Processing Pathway: Transport of Precursors of Major Histocompatability Complex Class I-Restricted Peptides from the Endoplasmic Reticulum to the Cytosol. JEM 186: 479-487 [Abstract] [Full Text]
Malarkannan, S., Serwold, T., Nguyen, V., Sherman, L.�A., Shastri, N. (1996). The mouse mammary tumor virus env gene is the source of a CD8+ T-cell-stimulating peptide presented by a major histocompatibility complex class I molecule in a murine�thymoma. Proc. Natl. Acad. Sci. USA 93: 13991-13996 [Abstract] [Full Text]
Hudrisier, D., Riond, J., Mazarguil, H., Gairin, J. E. (2001). Pleiotropic Effects of Post-translational Modifications on the Fate of Viral Glycopeptides as Cytotoxic T Cell Epitopes. J. Biol. Chem. 276: 38255-38260 [Abstract] [Full Text]
Rubio-Godoy, V., Dutoit, V., Rimoldi, D., Lienard, D., Lejeune, F., Speiser, D., Guillaume, P., Cerottini, J.-C., Romero, P., Valmori, D. (2001). Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life. Proc. Natl. Acad. Sci. USA 98: 10302-10307 [Abstract] [Full Text]